Sphingolipids: A Potential Molecular Approach to Treat Allergic Inflammation

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="center" colspan="4">Some common antihistamines</td></tr><tr class="thead"><td align="left">First generation</td><td align="center" colspan="2">Second generation</td><td align="center">Third generation</td></tr><tr class="thead"><td align="left">Systemic</td><td align="center">Systemic</td><td align="center">Topical</td><td align="center">Systemic/topical</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">Promethazine</td><td align="center">Cetirizine</td><td align="center">Azelastine</td><td align="center">Levocetirizine</td></tr><tr><td align="left">Pheniramine</td><td align="center">Loratadine</td><td align="center">Levocabastine</td><td align="center">Desloratadine</td></tr><tr><td align="left">Cyproheptadine</td><td align="center">Terfenadine</td><td align="center"> </td><td align="center">Fexofenadine</td></tr><tr><td align="left">Dexchlorpheniramine</td><td align="center">Ketotifen</td><td align="center"> </td><td align="center"> </td></tr><tr><td align="left">Trimeprazine</td><td align="center">Mizolastine</td><td align="center"> </td><td align="center"> </td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Common antihistamines marketed in Australia.

Journal of Allergy

tab1

Table 1

Table 1: Sphingolipids: A Potential Molecular Approach to Treat Allergic Inflammation 